Get started
Author

Fumie Okubo

A Comparison of Indocyanine Green Fluorescence Imaging Plus Blue Dye and Blue Dye Alone for Sentinel Node Navigation Surgery in Breast Cancer Patients
2012 · Akira Hirano, Mari Kamimura, et al. · Annals of Surgical Oncology · 74
The effect of anastrozole on bone mineral density during the first 5 years of adjuvant treatment in postmenopausal women with early breast cancer
2015 · Hiroaki Inoue, Akira Hirano, et al. · SpringerPlus · 8
PDF
Significance of Neoadjuvant Chemotherapy for Breast Cancer; Prediction of Prognosis according to Pathological Response
2012 · Akira Hirano, Tadao Shimizu, et al. · Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons) · 1
PDF
A Case of a Rapidly Enlarged Malignant Phyllodes Tumor of the Breast
2010 · Hiroaki Inoue, Akira Hirano, et al. · Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons) · 1
急速増大した乳腺悪性葉状腫瘍の１例
2010 · Hiroaki Inoue, Akira Hirano, et al. · Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons) · 1
PDF
Abstract OT2-2-07: A phase II study of S-1 (14 days' administration followed by 7 days' rest) for metastatic breast cancer
2015 · Akira Hirano, Akinori Hattori, et al. · Cancer Research
P205 The relationship between dose intensity and pathological effect of nab-paclitaxel as neoadjuvant
2015 · H. Inoue, A. Hirano, et al. · The Breast
P197 Phase II study of neoadjuvant weekly albumin-bound paclitaxel for node-positive breast cancer
2015 · A. Hirano, K. Ogura, et al. · The Breast
S-1-associated hand-foot syndrome as a prognostic factor in patients with metastatic breast cancer
2015 · Akira Hirano, Akinori Hattori, et al. · Annals of Cancer Research and Therapy
PDF
Epirubicin/Cyclophosphamide followed by Docetaxel as Primary Systemic Therapy in Breast Cancer
2014 · Akira Hirano, Mari Kamimura, et al. · Annals of Cancer Research and Therapy
PDF
The effect of anastrozole on bone mineral density during the first 5 years of adjuvant treatment in postmenopausal women with early breast cancer.
2013 · Hiroaki Inoue, Akira Hirano, et al. · Journal of Clinical Oncology
Epirubicin/cyclophosphamide followed by docetaxel as the primary systemic therapy for locally advanced breast cancer: The final analysis of a phase II study.
2013 · Akira Hirano, Mari Kamimura, et al. · Journal of Clinical Oncology
Abstract OT1-1-01: A phase II study of neoadjuvant epirubicin/cyclophosphamide (EC) followed by weekly nanoparticle albumin-bound paclitaxel with or without trastuzumab for node-positive breast cancer
2012 · A Hirano, A Hattori, et al. · Cancer Research
Comparison of indocyanine green (ICG) fluorescence imaging plus blue dye and blue dye alone in sentinel node navigation surgery (SNNS) for breast cancer.
2011 · A. Hirano, T. Shimizu, et al. · Journal of Clinical Oncology
[Responses to primary systemic therapy for breast cancer as assessed by hormone receptor and HER2 status].
2011 · Akira Hirano, Tadao Shimizu, et al. · PubMed
Paclitaxel Interstitial Pneumonitis Inducing in Locally Advanced Breast Cancer
2011 · Fumie Okubo, Tadao Shimizu, et al. · 日本外科系連合学会誌
Ｐａｃｌｉｔａｘｅｌ，ｔｒａｓｔｕｚｕｍａｂ併用術前化学療法後に間質性肺炎をきたした乳癌の１例
2011 · Fumie Okubo, Tadao Shimizu, et al. · Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons)
PDF
The effect of exemestane on bone mineral density during the first 3 years of adjuvant treatment of postmenopausal women with early breast cancer.
2010 · A. Hirano, T. Shimizu, et al. · Journal of Clinical Oncology
Works count: 18
Citation count: 85
H-index: 2
I10-index: 1
Year
Topic
Type